Early Release
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 4—April 2026
Synopses
- Pediatric Meningoencephalitis Cluster Caused by Snowshoe Hare Virus, Whistler, British Columbia, Canada, 2024
- Circulation Patterns, Genetic Diversity, and Public Health Implications of Enterovirus D68, Europe, 2014–2024
- Ecological Investigative Strategies to Determine Human Plague Exposure Sites, United States, 1991–2018
Research
-
Enhanced Detection of Coccidioides spp. Fungi from Environmental Samples Using Droplet Digital PCR
Coccidioidomycosis (Valley fever), caused by Coccidioides spp. fungi, is a reemerging, neglected fungal disease endemic to arid and semiarid regions of the Americas. Environmental detection remains challenging because of spatial heterogeneity, seasonal variability, low DNA abundance, PCR inhibitors, and lack of standardized methods. We conducted environmental surveillance in Baja California, Mexico, an understudied region near the US–Mexico border, by collecting 74 soil samples from active rodent burrows across 5 locations. We evaluated droplet digital PCR (ddPCR) for Coccidioides detection and compared ddPCR with nested PCR targeting the internal transcribed spacer 1 region. ddPCR demonstrated greater sensitivity, detecting Coccidioides spp. DNA at all sampling sites, whereas nested PCR detected Coccidioides spp. DNA from only 1 site. Although additional work is required to rigorously quantify sensitivity and specificity, ddPCR could help identify Coccidioides environmental hotspots, thus enabling public health interventions, such as warning communities of areas that pose higher risk for infection.
- Hemolytic Uremic Syndrome Outbreak in Adults and Shiga Toxin–Producing Escherichia coli Negative for Locus of Enterocyte Effacement, France, 2025
- Dengue Incidence, Seroprevalence, and Expansion Factors from Active Surveillance, Brazil, 2016–2021
-
Confirming ERVEBO Vaccination to Support Ebola Virus Surveillance
Accurate confirmation of Ebola vaccination (ERVEBO) is essential for interpreting serologic data and assessing vaccine coverage during Ebola virus (EBOV) outbreaks. Current GP1,2-based assays cannot reliably distinguish vaccine-induced immunity from responses generated by natural infection. We developed a multiplex Luminex assay incorporating EBOV GP1,2, secreted glycoprotein (sGP), and a modified vesicular stomatitis virus nucleoprotein (VSV-P-N), a vector antigen encoded by ERVEBO but absent from wild-type EBOV. By using samples from US vaccinees and controls and a small comparison set from the Democratic Republic of the Congo, we found sGP and VSV-P-N demonstrated 100% sensitivity and >97.6% specificity for identifying vaccinees. In samples collected after a ring vaccination campaign in Guinea, combined sGP and VSV-P-N positivity confirmed vaccination in 94.8% of persons with written and 90.8% of persons with verbal confirmation of vaccination history. Our findings show that sGP and VSV-P-N provide a reliable signature of ERVEBO vaccination and support improved Ebola surveillance.
- Respirable Aerosol Production and Reduction of Avian Influenza Transmission Risk during Chicken Processing, Bangladesh
-
Evaluation of Effectiveness of Autocidal Gravid Ovitraps for Preventing Zika Virus Infection, Puerto Rico, USA
Aedes aegypti mosquitoes drive arboviral outbreaks in tropical regions. Zika virus (ZIKV), linked to congenital and neurologic complications, caused a major outbreak in Puerto Rico, USA, in 2016, infecting ≈26% of the population. Autocidal gravid ovitraps (AGOs), pesticide-free devices targeting gravid Ae. aegypti mosquitoes, have been shown to reduce transmission of another arbovirus, chikungunya. During March–May 2017, we conducted a household-based serosurvey in 4 demographically similar communities in southeastern Puerto Rico, 2 with long-term AGO deployment (≈85% coverage) and 2 without, to assess effects of AGOs on ZIKV transmission. Among 271 participants >5 years of age, ZIKV seroprevalence was much lower in intervention than nonintervention communities (9.6% vs. 20.0%). Protective effects were strongest among older adults, larger households (>4 persons), and persons spending more time at home. Although study design and measurement limitations could limit generalizability of results, our findings support AGOs as sustainable nonchemical tools for reducing ZIKV infections.
-
Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus Infection in Humans and Domestic Ruminants, Democratic Republic of the Congo
Crimean-Congo hemorrhagic fever virus (CCHFV) was first isolated in the Democratic Republic of the Congo (DRC) in 1956. To date, only 3 sporadic human cases have been reported in the DRC, and data on CCHFV infection in livestock, which are key players in transmission, are scant. We conducted a cross-sectional seroepidemiological study on archived human and animal serum samples collected from 25 provinces across the DRC. Samples were tested using an ELISA detecting CCHFV nucleoprotein-specific antibodies. The seroprevalence of CCHFV infection in humans was 4.4% (55/1,239) and in domestic ruminants was 28.9% (322/1,114). High seroprevalences tended to correlate with increased age, specific climate conditions (e.g., tropical monsoon) and vegetation (e.g., mountain savanna) types, and higher elevation (>600 m). Our findings suggest that CCHFV actively circulates in animals and sporadically transmits to humans in the DRC, highlighting the need for continued surveillance of CCHFV infection.
-
Geographically Distinct Circulation of Genotype II and III St. Louis Encephalitis Virus, Texas, USA, 2009–2024
We conducted a retrospective genomic surveillance study of St. Louis encephalitis virus (SLEV) in Texas, USA, to determine the genotypes circulating in the region. By using a custom tiled-amplicon assay with Oxford Nanopore sequencing, we generated 63 genomes from SLEV-positive mosquito pools and viral isolates collected during 2009–2024. Phylogenomic analysis revealed temporal overlap of genotype II and III circulation, but with distinct geographic segregation. Genotype II was confined to Gulf Coast counties with sustained local transmission, whereas genotype III was only in north and West Texas, but with persistent circulation and repeated introductions. We identified the earliest known US genotype III sequences, although their phylogenetic placement leaves the entry point of genotype III into the United States unresolved. Our findings emphasize the need for clinical vigilance in West Texas, where SLEV and West Nile virus co-circulate, and suggest the Gulf Coast may be buffered against foreign genotype introduction.
-
Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa
The COVID-19 pandemic coincided with rising secondary bloodstream infections (BSIs) from multidrug-resistant organisms, including Candida auris. To assess candidemia trends, we conducted a retrospective analysis of blood culture isolates from public and private laboratories in South Africa taken during January 2019–June 2022. We evaluated weekly aggregated Candida BSI counts and COVID-19 cases using segmented regression within an interrupted time-series framework. In total, 15,393 candidemia cases were identified, 70% from the private sector. C. parapsilosis accounted for 39% of cases, whereas C. auris represented 26%. The proportion of C. auris increased significantly from 17% in 2019 to 31% in 2021 (p<0.01). After the pandemic onset, Candida BSIs rose by 11 cases per week (p = 0.03), largely driven by C. auris (+5 cases/week; p<0.01); peaks coincided with COVID-19 waves. Those results highlight an accelerated shift toward C. auris in Candida BSIs and the urgent need for enhanced surveillance, diagnostics, and infection prevention.
- Transmissibility and Disease Progression of Asymptomatic Mycobacterium Tuberculosis, Lima, Peru
-
Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023–2024
To evaluated artemisinin partial resistance (ART-R) in malaria in Burundi, during December 2023–June 2024, we studied 423 children <5 years of age with uncomplicated Plasmodium falciparum malaria in 8 health facilities in the northern part of the country. After artemether/lumefantrine treatment with only the first dose directly observed, 4.5% remained parasitemic on day 3. No pfkelch13 mutations, validated or candidate markers of ART-R, were detected. However, markers of antifolate and 4-aminoquinoline resistance were widespread: the dhfr triple mutant N51I/C59R/S108N was nearly fixed (92%), dhps double and triple mutants were common (41% and 47%), and pfcrt CVIET, associated with chloroquine and amodiaquine resistance, predominated (84%). Geographic differences occurred in day-3 positivity and haplotype frequencies. Although ART-R markers were absent, delayed parasite clearance and near fixation of multidrug-resistant haplotypes serve as a warning. Strengthened efficacy monitoring and regional molecular surveillance are urgently needed to prevent drug-resistant P. falciparum from becoming established in Burundi.
Dispatches
- Chronic Wasting Disease in Farmed Cervids, South Korea, 2001–2024
- Panton-Valentine Leukocidin–Encoding CC398 Methicillin-Resistant Staphylococcus aureus, the Netherlands, 2023–2024
- Outbreak of Dengue Virus Serotype 3, Republic of the Marshall Islands, 2019–2021
- Rapid Spread of Recombinant African Swine Fever Virus Genotypes I and II, Vietnam, 2023–2024
- Treatment of Severe Ocular Mpox with Cidofovir and Tecovirimat
- Recombinant mosaic Coxsackievirus A9 strain associated with severe inflammatory cardiomyopathy in a previously healthy child, Northeastern France, 2024
- Use of nitroxoline for disseminated Acanthamoeba infection presenting as necrotic skin lesions and granulomatous vasculitis in an elderly man on dupilumab
- Guillain-Barré Syndrome and Visual Impairment Associated with Emerging Oropouche Virus Lineage, Brazil, 2024
- Whole Genome Analysis of Treponema pallidum subsp. endemicum Among Men Who Have Sex with Men, Japan, 2020–2023
Photo Quiz
Research Letters
-
Rickettsia lanei Rickettsiosis, Oregon, USA, 2025
Using metagenomic sequencing, we identified a patient infected with Rickettsia lanei who was initially diagnosed with Rocky Mountain spotted fever (RMSF), a clinically similar disease caused by infection with R. rickettsii. Our investigation highlights the importance of clinical, epidemiologic, and laboratory partnerships to leverage the discovery of novel pathogens.
- Seroepidemiologic Study of Oropouche Virus, Amazonas State, Brazil, 2015–2016
- Acute Febrile Illness Surveillance Similar to Household Serosurvey for Population Immunity Estimates, Dominican Republic, 2021
Another Dimension
- The Weight of Waiting
Etymologia
About the Cover
Volume 32, Number 5—May 2026
Synopses
- Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related MLST Lineages, Japan
- Borna disease virus 1 infection causing fatal meningoencephalomyelitis in wild European hedgehogs in known endemic areas, Germany, 2022 to 2025
Research
- Zoonotic and Anthroponotic Plasmodium spp. Circulation between Wild Primates and Indigenous Community, Peruvian Amazon, 2007–2020
- Frequency, Duration, and Risk Factors for Diagnostic Delays Associated with Coccidioidomycosis
- Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August–November 2024
- Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States
Dispatches
- Detection of Human Rhinovirus B14 from Outbreak of Severe Respiratory Illness among Older Adults, France, 2024
-
Tropism and Replication Competence of Cattle Influenza A(H5N1) Genotype B3.13 Virus in Human Bronchus and Lung Tissue
In 2024, influenza A(H5N1) genotype B3.13 viruses emerged from cattle and caused mild spillover infections in humans. Using human bronchus and lung tissue, we evaluated tropism, replication, and pathogenesis of 2 cattle influenza isolates. Those viruses showed moderate replication competence and induced robust proinflammatory responses, suggesting potential risk for human health.
- Genomic Analysis of Sin Nombre Virus Genome Sequences, Northwestern United States, 2023
- Retrospective Phylogenetic Analysis of Mayaro Virus, French Guiana, 1996–2024
- Serologic Surveillance of Wildlife in High Pathogenicity Avian Influenza Virus Subtype H5 Hotspot, Northeast Germany, 2023–2025
- A One Health investigation into a fatal encephalitis caused by pigeon paramyxovirus type 1 (PPMV-1) infection in France
- Infection and exposure to the human tick-borne relapsing fever agent Borrelia persica in horses in Israel, 2025
- Repeated human cases of Cryptosporidium sp. OTUi in returned travelers: Clinical, molecular, and zoonotic perspectives
- Yezo Virus Diversity in Tick-Bitten Patients and Ticks, Russia
Research Letters
- Genomic Surveillance of Lassa Virus through In-Country Sequencing, Guinea
- Highly Pathogenic Avian Influenza A(H5N1) Viral RNA in Bovine Semen, California, USA, 2024
- Herpes Simplex Virus 1 in Trigeminal Ganglia of Trafficked Neotropical Primates
- Unmitigated serial interval and intervention efficiency in a school-based outbreak of pertussis, South Korea, 2024
Letters
- Comment on Chagas Disease, an Endemic Disease in the United States
- Evidence of Rat Hepatitis E Virus Circulation through Wastewater Surveillance, Central Argentina
Books and Media
- The Big One: How We Must Prepare for Future Deadly Pandemics
Etymologia
- Bacteria [bak-tēr′-ē-ә]
Volume 32, Number 6—June 2026
Synopsis
- Cerebrospinal Fluid Findings among Patients with Anaplasmosis and Central Nervous Involvement, Minnesota and Wisconsin, USA
Books and Media
- Dangerous Miracle: The Astonishing Rise and Looming Disaster of Antibiotics





